Vanderbilt University Medical Center (VUMC) is committed to excellence in patient care, leadership in research, and preeminence in medical education. Our culture thrives on challenges and champions innovation, while striving to make healthcare personal.
Vanderbilt University and Bristol-Myers Squibb Company announced that they have signed a collaboration agreement for the discovery, development and commercialization of novel therapies acting on the mGluR4 glutamate receptor, known as positive allosteric modulators or PAMs, for the treatment of Parkinson's disease.
Read More